期刊
BIOMETRIKA
卷 107, 期 1, 页码 107-122出版社
OXFORD UNIV PRESS
DOI: 10.1093/biomet/asz065
关键词
Nonparametric estimation; Proportion of treatment effect explained; Randomized clinical trial; Surrogate marker
资金
- NIDDK NIH HHS [R01 DK118354] Funding Source: Medline
In randomized clinical trials, the primary outcome, Y, often requires long-term follow-up and/or is costly to measure. For such settings, it is desirable to use a surrogate marker, S, to infer the treatment effect on Y, Delta. Identifying such an S and quantifying the proportion of treatment effect on Y explained by the effect on S are thus of great importance. Most existing methods for quantifying the proportion of treatment effect are model based and may yield biased estimates under model misspecification. Recently proposed nonparametric methods require strong assumptions to ensure that the proportion of treatment effect is in the range [0, 1]. Additionally, optimal use of S to approximate Delta is especially important when S relates to Y nonlinearly. In this paper we identify an optimal transformation of S, g(opt)(center dot), such that the proportion of treatment effect explained can be inferred based on g(opt)(S). In addition, we provide two novel model-free definitions of proportion of treatment effect explained and simple conditions for ensuring that it lies within [0, 1]. We provide nonparametric estimation procedures and establish asymptotic properties of the proposed estimators. Simulation studies demonstrate that the proposed methods perform well in finite samples. We illustrate the proposed procedures using a randomized study of HIV patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据